Affiliation:
1. Department of Biochemistry, Faculty of Science, University of Allahabad, Prayagraj-211002, UP, India
2. Department of Botany, W.R.S. Government College, Dehri, Kangra-176022, H.P, India
Abstract
Euglena, a microalga, has gained a great attention as it contains several bioactive compounds
including food supplements, drugs and biofuels. The genus Euglena includes >300 species
of unicellular, fresh water flagellates. The objective of this review article concerns the presentation
of updated information on pharmacological and therapeutic properties and industrial implications
of molecules isolated from Euglena species. A bibliographic search of scientific literature published
till March, 2020 was made from scientific databases using different search engines. Euglena
produces several antioxidant molecules, such as β-carotene, L-ascorbic acid, polymers of unsaturated
fatty acids and phytotoxins useful in manufacturing many pharmaceutical, cosmetics, and
nutraceutical compounds. It is a rich source of antimicrobial, anticancer, immunomodulatory compounds.
Though, several studies have indicated its therapeutic applications, extensive research is
needed to explore its efficacy against many pathophysiological conditions including toxicity assessment
of compound(s). Nevertheless, the biotechnological influence on industrial production of
Euglena has been less exploited.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献